AUTOMA+ 2025
Vösendorf, Austria
November 24-25, 2025
AUTOMA+ 2025 is a premier event for pharmaceutical leaders focused on digital transformation, automation, and innovation. The congress brings together top experts and companies like Merck KGaA, GSK, and Octapharma to share insights on AI-powered pharma, digital manufacturing, smart supply chains, and sustainability. Attendees benefit from high-level networking, practical case studies, and exposure to the latest technologies driving the industry forward.
A highlight of the event is the keynote by Dr. Ewa Gajewska, Head of Product Management, who leads the development of SYNTHIA® Retrosynthesis Software. Dr. Gajewska will present how SYNTHIA® is transforming drug discovery with AI-driven retrosynthesis, enabling faster, greener, and more cost-effective molecule design. Her talk offers valuable strategies for leveraging digital tools to accelerate R&D and achieve sustainability in pharmaceutical chemistry.
Don’t miss this opportunity to learn from industry pioneers, connect with peers, and discover how digital innovation can give your organization a competitive edge.
Speaker
Dr. Ewa Gajewska holds a position of a Head of Product Management in Merck, Darmstadt, Germany where she leads the development of SYNTHIA® Retrosynthesis Software. She graduated in biotechnology and chemistry from the Gdansk University of Technology and was a recipient of the Outstanding Achievements Award from Poland’s Minister of Science and Higher Education. In 2020 she received her PhD from the Institute of Organic Chemistry at the Polish Academy of Sciences. Her doctoral work was devoted to development of the SYNTHIA® Retrosynthesis Software for computer-assisted synthetic planning. Her passion for tackling complex scientific challenges within commercial settings and the unique blend of her interdisciplinary skills drive the realization of innovative features of SYNTHIA® Retrosynthesis Software.
